| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |